Does preoperative depression and/or serotonin transporter gene polymorphism predict outcome after laparoscopic cholecystectomy?

Barry Wright,David Alexander,Assad Aghahoseini,York Surgical Outcomes Research Team,Victoria Allgar,Tim Wilson,Sophie Bennett,Naveed Aziz,Danielle Collingridge-Moore,Marcus R Munafò,David Locker,Ian Holbrook,Kevin Anakwe,Naomi Hooke,Ben Alderson-Day,Conor Davidson,Heather Tomlinson,Celina Whalley
DOI: https://doi.org/10.1136/bmjopen-2015-007969
IF: 3.006
2016-09-01
BMJ Open
Abstract:OBJECTIVE: To determine whether preoperative psychological depression and/or serotonin transporter gene polymorphism are associated with poor outcomes after the common procedure of laparoscopic cholecystectomy.DESIGN: Patients undergoing laparoscopic cholecystectomy were genotyped for the serotonin transporter gene 5-HTTLPR polymorphism and assessed for psychological morbidity before and 6 weeks after surgery. The main outcome was postoperative depression; secondary outcomes included fatigue, perceived pain, quality of life and subjective perception about return to usual.RESULTS: Full genetic and psychological data were obtained from 273 out of 330 patients consented to the study (82% female). Significantly fewer people with preoperative depression (Beck Depression Inventory (BDI) score >5) had returned to employment (57% vs 86%, p<0.001) or made a full recovery (11% vs 44%, p<0.001) 6 weeks after surgery. Independent predictors for subjective return to usual after surgery included preoperative depression, body mass index and postoperative pain scores. Independent predictors of postoperative depression included preoperative antidepressant use and preoperative depression. SS genotype was associated with use of antidepressants preoperatively and higher anxiety levels after surgery. However, it was not associated with other salient postoperative psychosocial outcomes.CONCLUSIONS: Depressive psychological morbidity preoperatively, pain and body mass index appear to be important factors in predicting recovery after this common surgical procedure. There may be a place to include preoperative brief psychological screening to enable targeted support. Our results suggest that the serotonin transporter gene is unlikely to be a useful clinical predictor of outcome in this group.TRIAL REGISTRATION NUMBER: ISRCTN40219584.
medicine, general & internal
What problem does this paper attempt to address?